share_log

CVS Health | DEF 14A: Definitive information statements

CVS Health | DEF 14A: Definitive information statements

西维斯健康 | DEF 14A:股东委托书决议
美股SEC公告 ·  04/06 04:10

Moomoo AI 已提取核心信息

CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments...Show More
CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments. The Board of Directors recommends voting for the election of directors, ratification of the accounting firm, executive compensation, and the amendment to the incentive plan, and against all stockholder proposals. The meeting will also include a business presentation and a Q&A session. Shareholders as of the record date, March 18, 2024, are entitled to vote and have been provided with various methods to submit their votes.
CVS Health Corporation(CVS Health)定于美国东部时间2024年5月16日上午8点举行年度股东大会。会议将以虚拟方式进行,允许股东无论身在何处都能参加。该议程包括董事选举、批准2024年独立注册会计师事务所、咨询批准高管薪酬,以及修改2017年激励性薪酬计划以增加批准发行股票数量的提案。此外,还将考虑四项股东提案,包括一项独立的工人权利评估、一项禁止重新提名未能获得多数票的董事的政策、对 “过多” 金色降落伞的投票,以及一项要求董事披露其在承诺中的时间分配的政策。董事会建议对董事选举、批准会计师事务所、高管薪酬和激励计划修正进行投票,并反对所有股东提案。会议还将包括业务演示和问答环节。截至记录日期,即2024年3月18日,股东有权投票,并已获得各种提交选票的方法。
CVS Health Corporation(CVS Health)定于美国东部时间2024年5月16日上午8点举行年度股东大会。会议将以虚拟方式进行,允许股东无论身在何处都能参加。该议程包括董事选举、批准2024年独立注册会计师事务所、咨询批准高管薪酬,以及修改2017年激励性薪酬计划以增加批准发行股票数量的提案。此外,还将考虑四项股东提案,包括一项独立的工人权利评估、一项禁止重新提名未能获得多数票的董事的政策、对 “过多” 金色降落伞的投票,以及一项要求董事披露其在承诺中的时间分配的政策。董事会建议对董事选举、批准会计师事务所、高管薪酬和激励计划修正进行投票,并反对所有股东提案。会议还将包括业务演示和问答环节。截至记录日期,即2024年3月18日,股东有权投票,并已获得各种提交选票的方法。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息